Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Chameleon Biosciences

Request full access

Transforming gene therapy with a re-dosable, AAV based gene therapy

Berkeley, United StatesFounded 2017Biotech & Life Sciences

About Chameleon Biosciences

Chameleon Biosciences is a biotechnology company focused on developing gene therapies for rare genetic disorders. The company operates in the healthcare and biotechnology market, specifically targeting conditions such as Niemann-Pick Type C, Hemophilia, Duchenne Muscular Dystrophy, and other severe genetic diseases. Chameleon Biosciences serves patients and healthcare providers by offering innovative treatments designed to address significant unmet medical needs. The business model revolves around research and development of gene therapies, conducting clinical trials, and eventually commercializing these therapies. Revenue is generated through the sale of these therapies, partnerships with pharmaceutical companies, and potential licensing agreements. The company's mission is to provide life-changing, re-dosable gene therapies that offer longer, healthier lives for patients, including children and adults.

Source: Dealroom company data

Chameleon Biosciences in the Berkeley ecosystem

Live from Dealroom

The Chameleon Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇪🇸 Spain100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Chameleon Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Chameleon Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.